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Abstract
Introduction: b2R1-fructans are dietary fibers. Main objectives of this study were 1) to demonstrate direct signalling of
b2R1-fructans on immune cells, 2) to study whether this is mediated by the pattern recognition receptors Toll-like
receptors (TLRs) and nucleotide-binding oligomerisation domain-containing proteins (NODs), and 3) to relate the observed
effects to the chain length differences in b2R1-fructans.
Methods: Four different b2R1-fructan formulations were characterised for their chain length profile. Human peripheral
blood mononuclear cells (PBMCs) were stimulated in vitro with b2R1-fructans, and production of IL-1Ra, IL-1b, IL-6, IL-10,
IL-12p70, and TNF-a was analysed. Reporter cells for TLRs and NODs were incubated with b2R1-fructans and analysed for
NF-kB/AP-1 activation.
Results: Cytokine production in human PBMCs was dose- and chain length-dependent. Strikingly, short chain enriched
b2R1-fructans induced a regulatory cytokine balance compared to long chain enriched b2R1-fructans as measured by IL-
10/IL-12 ratios. Activation of reporter cells showed that signalling was highly dependent on TLRs and their adapter, myeloid
differentiation primary response protein 88 (MyD88). In human embryonic kidney reporter cells, TLR2 was prominently
activated, while TLR4, 5, 7, 8, and NOD2 were mildly activated.
Conclusions: b2R1-fructans possess direct signalling capacity on human immune cells. By activating primarily TLR2, and to
a lesser extent TLR4, 5, 7, 8, and NOD2, b2R1-fructan stimulation results in NF-kB/AP-1 activation. Chain length of b2R1-
fructans is important for the induced activation pattern and IL-10/IL-12 ratios.
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Introduction
High fiber intake is associated with lower mortality in subjects
suffering from circulatory, digestive, and non-cardiovascular non-
cancerous inflammatory diseases [1-3]. These associations are
similar for men and women and are observed in most countries
even after careful adjustment for potentially confounding lifestyle
and dietary differences [4]. The mechanisms by which fibers
contribute to reduced mortality remain to be identified but have
been suggested to be of both metabolic and immunological nature
[5]. Cereal fibers have been associated with lower concentrations
of inflammatory biomarkers [4], but there is an urgent need for
studies addressing specific fibers [4] to obtain a better under-
standing of mechanisms and components underlying protective
associations.
One of the many types of dietary fibers which have been
reported to elicit health benefits are linear b2R1-fructans (also
named inulin-type fructans, ITFs, or fructooligosaccharides).
These fructans are made up of fructose subunits, can vary
considerably in chain length, and occur with or without the
presence of a terminal glucose moiety [6]. The fructose oligomers
are denoted as Fn or GFn (n = number of fructose subunits,
GFn = fructose chain terminated with a glucose molecule) [6]. The
chain length can also be denoted by the Degree of Polymerisation
(DP), representing the number of monosaccharide subunits in the
chain [6]. Whether these variations in composition cause different
physiological responses is currently unknown. Ingestion of b2R1-
fructans induces specific effects on the immune system, as recently
reviewed [7-11]. Changes in immunological parameters have been
reported in the gut lumen, Peyer’s patches, spleen, and blood [12-
14]. These effects could be induced via a prebiotic mechanism by
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stimulating beneficial (‘‘probiotic’’) bacteria in the intestine, such
as bifidobacteria and lactobacilli [10]. This can coincide with
modulation of fermentation products such as increased production
of short chain fatty acids [15,16], which affect the recruitment of
leukocytes to inflammatory sites [17,18], and suppress the
production of pro-inflammatory cytokines and chemokines [18-
20]. Besides through these more indirect effects on the microbiota
and its fermentation products, another pathway of modulation is
gaining attention, i.e. through direct signalling on immune cells.
This theory is supported by new insights into the structural and
functional makeup of the intestine [21,22]. Some dietary fibers
such as b-glucans, modulate the human immune system by
binding to pattern recognition receptors (PRRs) on cells of the
innate immune system, such as Dectin-1 and Toll-like receptors
(TLRs) [23-25]. These PRRs recognise so-called pathogen-
associated molecular patterns (PAMPs), which are small molecular
motifs found on groups of pathogens but also on many
microorganisms with beneficial or no effects on host health [26].
Because of their ability to recognise specific carbohydrate moieties
and elicit immune responses, we hypothesised that PRRs, and
more specifically TLRs and NODs are activated by b2R1-
fructans, and that this is one of the pathways by which b2R1-
fructans can influence the human immune system [27,28].
As little knowledge is available on the specific immunomodu-
lating effects of different types of b2R1-fructans, we investigated
the effect of b2R1-fructans with different chain lengths on
cytokine release by human Peripheral Blood Mononuclear Cells
(PBMCs) and we studied whether and which PRRs are involved in
b2R1-fructan recognition. Our studies support the concept that
ITFs can signal directly on immune cells via TLRs and that chain
length differences in ITFs can differentially affect immunological
parameters.
Materials and Methods
Ethics Statement
Chemical analyses (HPAEC and HPSEC) were performed at
Wageningen University. Other experiments, including blood
sampling of human volunteers, were conducted within the
University Medical Center Groningen, in the Netherlands.
Written informed consent was obtained, and data were analysed
and presented anonymously. This research and consent procedure
have been approved by the ethical review board of the University
Medical Center, Medisch Ethische Toetsingscommissie University
Medical Center Groningen, as documented in the approved
application ‘‘2007/255’’. All clinical investigation was conducted
according to the principles expressed in the Declaration of
Helsinki.
High Performance Anion Exchange Chromatography
Four different b2R1-fructan formulations were selected and
their specific chain length profiles (range and distribution) were
characterised by High Performance Anion Exchange Chroma-
tography (HPAEC). The applied b2R1-fructans were extracted
from chicory root and comprise a mixture of different chain
lengths varying from DP 2 to 60, referred to as inulin or native
inulin [29]. These chicory root b2R1-fructan chains are
terminated by a glucose molecule [6]. Fructans of varying DP
can be acquired by partial enzymatic hydrolysis of this extract
resulting in GFn and Fn chains with GFn ranging from DP 2 to 10
[6]. Another way to obtain b2R1-fructans is to synthesise them
from sucrose, resulting in GFn type fructans with DP 2-4 [30].
The following b2R1-fructan formulations were analysed: ITF I
(FrutaloseOFP) ITF II (FrutafitCLR), ITF III (FrutafitIQ),
and ITF IV (FrutafitTEX!). b2R1-fructan formulations were
provided by Sensus B.V., Roosendaal, The Netherlands. Endo-
toxin levels (endotoxin units, EU) of all used b2R1-fructan
samples were assessed by Toxikon (Leuven, Belgium) and were
below 0.3 x 10-3 mg-1.
For HPAEC, a Dionex ICS 3000 system (Dionex), equipped
with a Dionex CarboPac PA-1 column (2 x 250 mm) in
combination with a CarboPac PA-1 guard column (2 x 50 mm)
was used. Sample concentrations of 0.05–0.1 mg/ml and partial-
loop injection of 10 ml were applied. The system was equipped
with pulsed amperometric detection. Elution was performed at
0.3 ml/min. and oligomers were separated using a gradient as
follows: 0-400mM NaOAc in 100 mM NaOH within 40 min.,
followed by a 5 min. washing step (1M NaOAc in 100 mM
NaOH), and 15 min. equilibration (100 mM NaOH).
High Pressure Size Exclusion Chromatography
b2R1-fructan formulations were tested for their elution profile
using High Performance Size Exclusion Chromatography
(HPSEC) on Dionex Ultimate 3000 HPLC (Dionex, Sunnyvale,
CA, USA). The analysis was performed on three TSK-Gel
columns connected in series (4000-3000-2500 SuperAW; 150 x
6 mm). The columns were preceded by a TSK Super AW-L guard
column (35 x 4.6 mm). All columns were from Tosoh Bioscience
(Tokyo, Japan). Elution was performed at a flow rate of 0.6 ml/
min. using sodium nitrate (0.2 M) as the eluent. A volume of 20 ml
of the sample (2.5 mg/ml) in millipore water was injected and
eluted at 55uC. Solubles were detected using a refractive index
detector, Shodex type RI 101 (Showa Denko, Japan). The software
used for acquiring the data was Chromeleon version 7. Molecular
weight distribution of polysaccharides was determined using
pullulan standards (Polymer Laboratories, Varian Inc., Palo Alto,
CA, USA) in the molecular mass range of 0.18 - 790 kDa.
Isolation Human Peripheral Blood Mononuclear Cells
Human PBMCs were used to study whether b2R1-fructans can
signal on immune cells, especially since PBMCs express many
PRRs such as TLRs [31,32] and NODs [33]. Peripheral blood
from human volunteers was collected in heparinised tubes (15 IU/
ml lithium-heparin, Becton Dickinson B.V., Breda, The Nether-
lands) and PBMCs were isolated by Ficoll density gradient
separation (Lymphoprep, Axis-Shield, Oslo, Norway). Cells were
kept in RPMI1640 medium (Gibco, Life Technologies, Bleiswijk,
The Netherlands) supplemented with 10% Fetal Bovine Serum
(FBS, HyClone, Thermo Scientific, Breda, The Netherlands) and
50 mg/ml gentamicin (Gibco).
Cytokine Expression
As a read out for PBMC activation, cytokine production in the
medium was analysed after stimulation of PBMCs with a
concentration series of b2R1-fructans. To evaluate whether
b2R1-fructans induce a more anti-inflammatory or pro-inflam-
matory effect, and whether chain length profile would affect this
balance, the IL-10/IL-12 ratio was calculated for each b2R1-
fructan formulation at 1 mg/ml or 100 mg/ml. In this context, a
higher IL-10/IL-12 ratio is representative of a more anti-
inflammatory effect [34,35]. Human PBMCs (n= 6; 3 males, 3
females, age 25-42 yr., healthy non-smoker volunteers) were
seeded in a 24 wells plate at a density of 26106 cells/well with a
final volume of 1 ml/well. To characterise possible effects of
different chain length profiles on cytokine expression, the b2R1-
fructan formulations ITF I to IV were dissolved in culture medium
and added to the PBMCs at final concentrations ranging from 1 to
100 mg/ml. After 24h of incubation (37uC, 5% CO2) cytokine
b2R1-Fructans and Immune Modulation
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levels in the supernatant were measured using a Bio-PlexTM
premixed cytokine assay, human 6-plex group I; cat.#:
M5000B6CPS, control 5022016, according to the manufacturer’s
instructions. (Bio-rad Laboratories, Veenendaal, The Nether-
lands). This customised kit simultaneously measured human IL-
1Ra, IL-1b, IL-6, IL-10, IL-12p70, and TNF-a. Concentration
series of cytokine standards were prepared for the appropriate
concentration range, and coupled beads were diluted ten times,
resuspended, and added to a pre-wetted filter plate. After washing
the plate twice, standards, negative controls, and samples (all in
duplicate) were transferred into the plate (50 ml per well), and the
plate was sealed and incubated on a shaker at room temperature
(RT) for 30 min. After incubation, the plate was washed three
times, detection antibodies were resuspended and diluted ten times
and 25 ml was added to each well. The plate was incubated on a
shaker at RT for 30 min., and after washing three times, 50 ml of
streptavidin-phycoerythrin was added to each well and the plate
was incubated on a shaker at RT for 10 min. After washing the
plate three times, 125 ml of assay buffer was added per well, the
plate was incubated on a shaker for 5 min. and fluorescence was
measured using a Luminex 100 System and StarStation software.
All procedures as of the incubation with detection antibodies were
performed in the dark.
Cell Culture of Reporter Cell Lines
Selection media, Normocin antibiotic, Quanti-blue reagent,
TLR agonists and the following TLR-, and NOD-reporter cell
lines were acquired from InvivoGen (InvivoGen, Toulouse,
France). Two THP-1 human acute monocytic leukemia reporter
cell lines were acquired from Invivogen, both endogenously
expressing human TLRs and with inserted construct for Secreted
Embryonic Alkaline Phosphatase (SEAP) coupled to the NF-kB/
AP-1 promoter. The first of these THP-1 cell lines carries extra
inserts for MD2 and CD14 to boost TLR signalling, and the
second THP-1 cell line expresses only a truncated, non-functional
form of the TLR adapter MyD88. Nine different human
Embryonic Kidney (HEK293)-Blue reporter cell lines were
purchased from Invivogen, each with a different inserted construct
for either human TLR2, TLR3, TLR4, TLR5, TLR7, TLR8,
TLR9, NOD1, or NOD2, and all nine cell lines carrying an
inserted construct for Secreted Embryonic Alkaline Phosphatase
(SEAP) coupled to the NF-kB/AP-1 promoter. Both THP-1 cell
lines were maintained in RPMI1640 containing 10% heat
inactivated FBS, NaHCO3 (Boom B.V. Meppel, The Netherlands;
1,5 g/l), L-glutamine (2 mM), glucose (4,5 g/l), HEPES (10 mM),
sodium pyruvate (1 mM) penicillin/streptomycin (50 U/ml and
50 mg/ml), all from Sigma-Aldrich Chemie B.V., Zwijndrecht,
The Netherlands, and Normocin (100 mg/ml). Both THP-1 cell
lines were kept at a concentration of 56105 cells/ml. HEK-Blue
cells were maintained in DMEM (Life Technologies Europe B.V.)
containing 10% heat inactivated FBS, L-glutamine (2 mM),
glucose 4,5 g/l), penicillin/streptomycin (50 U/ml and 50 mg/
ml), and Normocin (100 mg/ml). HEK cells were grown to ,80%
confluency. After culturing for 3 passages, all reporter cell lines
were maintained in selection media according to the manufactur-
er’s protocol.
Reporter Cell Stimulations and Quanti-BlueTM Analysis
THP-1 cells were centrifuged for 5 min. at 300 g to collect the
cells and resuspended to the cell density specified by the
manufacturer’s protocol (Table 1). In a flat bottom 96 wells plate,
100 ml of this cell suspension per well was stimulated for 24 h
(37uC, 5% CO2) with 10 ml of stimulus, i.e. concentration series
(1 mg/ml - 2 mg/ml) of b2R1-fructan formulations ITF I to IV,
or the relevant positive control as indicated by the manufacturer’s
protocol (Table 1). Plain culture medium and endotoxin-free water
were applied as negative controls. After incubation, 20 ml of cell
culture medium of stimulated reporter cells was incubated with
180 ml of Quanti-blue reagent in a new flat bottom 96 wells plate
for 45 min at 37uC and SEAP activity (absorbance), representing
activation of NF-kB/AP-1, was measured at 650 nm on a
VersaMax microplate reader (Molecular Devices GmbH, Biber-
ach an der Riss, Germany) using SoftMax Pro Data Acquisition &
Analysis Software. HEK-Blue reporter cells were rinsed with
medium to detach them from the culture flask and cells were
resuspended to the cell density specified by the manufacturer’s
protocol (Table 1). 180 ml of cell suspension per well was
stimulated for 24 h (37uC, 5% CO2) with 20 ml of b2R1-fructan,
endotoxin free water, plain culture medium or positive control
(Table 1) in a flat bottom 96 wells plate. For all HEK cell lines,
after incubation, analysis of SEAP was performed in the same way
as described for the THP-1 cells.
Statistical Analysis
Significance levels were determined by parametric Student’s t-
test for unpaired observations (two-tailed) or by non-parametric
Mann-Whitney U-test for unpaired observations (two-tailed).
Results are expressed as mean 6 SEM or mean 6 SD
respectively. A P-value ,0.05 was considered statistically signif-
icant. P-values ,0.05 are denoted with *, P-values ,0.01 are
denoted with **, and P-values ,0.001 are denoted with ***.
Results
Chemical Characterisation of b2R1-fructan Formulations
The oligomer profiles of four b2R1-fructan formulations were
characterised using HPAEC and HPSEC. Figure 1A depicts the
oligosaccharide range and relative response per oligomer of the
b2R1-fructan formulations tested with HPAEC. Figure 1B
represents the HPSEC analysis of the four different b2R1-fructan
formulations, showing the elution patterns as a measure for the
molecular size distributions of these compounds in kDa. The
HPSEC analysis corroborated the observed chain length profiles
from the HPAEC analysis and in addition this method rendered a
visual representation of the degree in which the different chain
lengths are present per analysed formulation. The most important
differences can be observed between ITF I and II as compared to
ITF III and IV. ITF I can described as fructooligosaccharide
(FOS) with mostly chain lengths of DP,10, and ITF II can be
described as a FOS-enriched inulin, with a large proportion of
chains smaller than DP10, but also containing chains with DP up
to 25. ITF III and IV are described as ‘‘inulin’’ due to their broad
range of chain lengths present (up to DP60). ITF I and II contain
mostly chains of the type GF3, GF4, and GF5, (i.e. starting with a
glucose molecule followed by 3, 4, or 5 fructose subunits) and F3,
F4, or F5 (chains consisting only of 3, 4, or 5 fructose moieties).
Between ITF I and II, ITF I contains relatively more Fn type
oligosaccharides and ITF II contains relatively more GFn type
molecules. ITF III and IV consist solely of the GFn type fructans
while ITF I and II consist of both GFn and Fn fructans. Glucose
and fructose monomers, and GF and GF2 (i.e. dimers of glucose
and fructose subunits and trimers made up of one glucose subunit
and two fructose subunits) are present in all four ITFs.
b2R1-fructans Induce Cytokine Production in Human
PBMCs
To gain insight into dose effects and to determine which
cytokines are induced by b2R1-fructans we first screened for a
b2R1-Fructans and Immune Modulation
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panel of pro- and anti-inflammatory cytokines, i.e. IL-1b, IL-6, IL-
12, TNF-a, IL-1Ra, and IL-10, after stimulating human PBMCs
for 24 hours with b2R1-fructans. This was done for ITF I, in
doses of 1/2,5/5/10, and 100 mg/ml. As shown in Figure 2, IL-
1Ra expression was decreased for lower doses (2,5 to 10 mg/ml
b2R1-fructans) and increased at 100 mg/ml b2R1-fructans
(p,0.05, panel A). The same pattern was observed for IL-6;
expression was decreased for 2.5 mg/ml (p,0.05) and a substantial
increase was observed at 100 mg/ml (p,0.01, panel C). IL-10
expression was increased, especially at 1 mg/ml (p,0.001) and
100 mg/ml (p,0.0001, panel D). A small increase for TNFa was
observed at 100 mg/ml (12%, p,0.05, panel F). Since a dose as
low as 1 mg/ml induced a significant increase for IL-10, and
100 mg/ml induced significant and substantial increases, these low
end and high end doses were subsequently used for further
cytokine measurements in PBMCs.
Inulin-type Fructan-induced Cytokine Production by
Human PBMCs is Chain Length Dependent
To gain insight into size-response relationships, we investigated
whether the chain length of b2R1-fructans has an effect on the
type and quantity of cytokines produced by PBMCs. ITF I to IV
were tested at the concentrations of 1 and 100 mg/ml. IL-6 and
IL-10 were mainly induced by ITF I and ITF II (Fig. 3) which can
therefore be mainly attributed to short chain molecules enriched in
these formulations, i.e. F2-F5 and GF2-GF5 respectively. Produc-
tion of IL-12 was slightly increased by ITF II and strongly induced
by ITF III and IV, indicating that longer chains (.DP8, GFn type)
have to be held responsible for this effect. Similarly, the highest
production of TNF-a was observed after incubation with ITF IV.
These combined results showed that chain length profile of b2R1-
fructan formulations is an important determinant of the cytokine
profile which is induced upon stimulation.
Next, the IL-10/IL-12 ratios were calculated to quantify
whether there is a correlation between chain length profile and
cytokine balance (Fig.4). IL-10/IL12 ratios can be applied to
calculate the regulatory effects of bioactive food components [36].
Controls were set to 100, and a ratio of more than 100 was
considered to be regulatory or anti-inflammatory, whereas a ratio
lower than 100 was considered to be proinflammatory. Strikingly,
the IL-10/IL-12 ratios gradually decreased in the sequence of ITF
I.ITF II.ITF III.ITF IV, indicating that shorter chain fructans
induce a regulatory cytokine balance in human PBMCs compared
to longer chain fructans. When taking the structural differences
into consideration (Fig.1) it can be concluded that the molecules
F2-F5 and/or GF2-GF5, which are enriched in ITF I and II, skew
the IL-10/IL-12 ratio in PBMCs more towards IL-10, and thus
induce a more anti-inflammatory balance.
TLR Mediated Activation of NF-kB/AP-1 by b2R1-
fructans is Dependent on the Presence of Functional TLR
Adapter MyD88
Next, we investigated whether the activation of immune cells
can be explained by activation of PRRs by the b2R1-fructans. To
this end we applied the following strategy. First, b2R1-fructans
were tested for the ability to induce NF-kB/AP-1 transcription in a
THP-1 reporter cell line which endogenously expresses all TLRs,
and carries extra inserts for co-signalling molecules CD14 and
MD2 to increase the TLR-mediated responses. NF-kB and AP-1
are essential transcription factors in signalling for cytokine release
[37].
ITF I and II induced a statistically significant elevation of NF-
kB/AP-1 activation in THP-1 MD2-CD14 cells, while ITF III and
ITF IV only induced activation at higher doses (Fig.5). The
strongest activation was observed for ITF II, which is mainly short
chain GFn. Next, we investigated whether the activation was TLR-
dependent by testing the effect of b2R1-fructans on a specific
THP-1 reporter cell line carrying the truncated TLR adapter
molecule MyD88. These THP-1 DefMyD cells express only non-
functional MyD88, whereas the functional MyD88 is an essential
adapter molecule for TLR2, 4, 5, 7, 8, and 9 signalling. The
b2R1-fructan doses which significantly activated THP-1 MD2-
CD14 cells were subsequently tested in the THP-1 DefMyD cells.
b2R1-fructan mediated NF-kB/AP-1 activation appeared to be
TLR dependent as the activation pattern as observed in THP-1
MD2-CD14, was virtually absent in the MyD88 deficient cell line.
This indicated that b2R1-fructan mediated signalling to NF-kB/
AP-1 was TLR2, 4, 5, 7, 8, and/or 9 dependent. Slight activation
of THP-1 DefMyD cells by ITF IV suggests that other activation
pathways independent of MyD88 may also have been induced by
high concentrations of the longer chain b2R1-fructans which are
enriched in this ITF.
Table 1. Cell densities and positive controls used in reporter cell stimulations.
Cell line Cell density Positive control
THP-1 MD2-CD14 1*106 cells/ml E.coli K12 lipopolysaccharide Ultrapure (LPS, 100 ng/ml)
THP-1 DefMyD 2*106 cells/ml L-Ala-gamma-D-Glu-mDAP (TriDAP, 10 mg/ml)
HEK-Blue TLR2 2.8*105 cells/ml Pam2CGDPKHPKSF (FSL-1, 1 mg/ml)
HEK-Blue TLR3 2.8*105 cells/ml Poly(I:C) high molecular weight (HMW, 1 mg/ml)
HEK-Blue TLR4 1.4*106 cells/ml E.coli K12 lipopolysaccharide Ultrapure (LPS, 100 ng/ml)
HEK-Blue TLR5 1.4*106 cells/ml Recombinant flagellin from S.typhimurium (Rec-FLA-ST,100 ng/ml)
HEK-Blue TLR7 2.2*106 cells/ml Imiquimod (5 mg/ml)
HEK-Blue TLR8 2.2*106 cells/ml Single stranded RNA (ssRNA40/LyoVecTM, 5 mg/ml)
HEK-Blue TLR9 4.5*106 cells/ml Type B CpG oligonucleotide (ODN 2006, 100 mg/ml)
HEK-Blue NOD1 2.8*106 cells/ml L-Ala-gamma-D-Glu-mDAP (TriDAP, 10 mg/ml)
HEK-Blue NOD2 1.4*106 cells/ml MurNac-L-Ala-gamma-D-Glu-mDAP (M-TriDAP, 10 mg/ml)
doi:10.1371/journal.pone.0068367.t001
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Figure 1. HPAEC profiles and HPSEC elution patterns of different b2R1-fructan formulations. Figure A depicts the fructose (F) and
glucose (G) monomers, dimers, and fructan oligomers present in the ITF formulations. GFn chains are terminated by a glucose molecule, and Fn chains
consist of only fructose moieties. In both cases, n represents the number of fructose moieties in the chain. Figure B depicts the elution patterns as a
measure for molecular weight distribution profiles of the four different b2R1-fructan formulations in kDa.
doi:10.1371/journal.pone.0068367.g001
b2R1-Fructans and Immune Modulation
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Figure 2. Induction of cytokines by ITF I, in a dose range of 0 to 100 mg/ml. Statistical significance levels were determined with a parametric
Student’s t-test for unpaired observations (two-tailed). Mean and SEM of cytokine production is plotted as percentage of controls, which were set to
100% (n= 4). Panels A to F show the results for IL-1Ra, IL-1b, IL-6, IL-10, IL-12, and TNF-a respectively.
doi:10.1371/journal.pone.0068367.g002
b2R1-Fructans and Immune Modulation
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Figure 3. Induction of cytokines by b2R1-fructan formulations with different chain length (DP range), at 0, 1, and 100 mg/ml.
Statistical significance levels were determined with a non-parametric Mann-Whitney U-test for unpaired observations (two-tailed). Mean and SD of
cytokine expression are plotted as percentage of controls (represented by 0 mg/ml), which were set to 100% (n= 6). Panel A to D represent cytokine
expression induced by ITF I to IV respectively.
doi:10.1371/journal.pone.0068367.g003
Figure 4. Ratio of IL-10/IL-12 upon incubation of PBMCs with different chain length b2R1-fructans. PBMCs (n = 6) were stimulated with
1 mg/ml (panel A) and 100 mg/ml (panel B) b2R1-fructans for 24h. Statistical significance levels were determined with a non-parametric Mann-
Whitney U-test for unpaired observations (two-tailed). Mean and SD of the IL-10/IL-12 ratios is plotted for the different b2R1-fructans as percentage
of controls, which were set to 100% (n= 6) and horizontal bars indicate the significant differences between b2R1-fructan treatments.
doi:10.1371/journal.pone.0068367.g004
b2R1-Fructans and Immune Modulation
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b2R1-fructans Induce Strong Dose Dependent
Activation of TLR2, Slight Activation of TLR4, 5, 7, 8, and
NOD2, but No Activation of TLR3, TLR9, or NOD1
The results from the THP-1 cell stimulations showed that TLRs
are involved in b2R1-fructan signalling. Next, we investigated
which TLRs are specifically activated by b2R1-fructans and
whether the intracellular PRRs NODs were activated. To this end,
HEK reporter cell lines, each carrying one construct for a specific
TLR or NOD, were stimulated with b2R1-fructans in the same
way as described for the THP-1 cells (Fig.6). Strikingly, HEK cells
with TLR2 construct were strongly and dose dependently
activated by the b2R1-fructans. Moreover, this response was
chain length dependent, as NF-kB/AP-1 activation in HEK TLR2
cells increased with increasing chain length in the sequence of ITF
I,ITF II,ITF III,ITF IV. In these cells, long chain fructans
induced the strongest activation, up to 6-fold induction as
compared to control. To a lesser extent, HEK cells carrying
either TLR4, 5, 7, 8, or NOD2 were activated upon b2R1-
fructan stimulation. HEK cells expressing TLR3, 9 or NOD1 were
Figure 5. NF-kB/AP-1 activation in THP-1 MD2-CD14 and THP-1 defMyD reporter cells. Statistical significance levels were determined with
a non-parametric Mann-Whitney U-test for unpaired observations (two-tailed). Mean and SD of NF-kB/AP-1 activation by b2R1-fructans of different
chain lengths (ITF I, II, III and IV) are plotted as percentage of negative controls (unstimulated cells), which were set to 100% for both cell lines. LPS
stimulation was used as a common positive control for TLR4/MyD88 signalling to NF-kB/AP-1 in the functional THP-1 MD2-CD14 cell line. TriDAP was
used as a positive control in THP-1 DefMyD cells, which induces MyD88-independent signalling to NF-kB/AP-1. Panel A to D represent cytokine
expression induced by ITF I to IV respectively. Only concentrations which induced activation in the THP-1 MD1-CD14 cells are shown for comparison
of these concentrations in the THP-1 DefMyD cells.
doi:10.1371/journal.pone.0068367.g005
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not significantly activated by b2R1-fructan stimulation (data not
shown). These data combined show that TLR binding was b2R1-
fructan type-, and thus chain length dependent.
Discussion
We hypothesised that b2R1-fructans can affect the immune
status through physical contact with pattern recognition receptors
(PRRs) on gut immune cells such as intra-epithelial lymphocytes
[38] or DCs [27,28]. As TLR activation in PBMCs leads to
cytokine production [31,39], we used these cells to test whether
b2R1-fructans would also induce production of cytokines. Both
anti-inflammatory and proinflammatory cytokines were produced,
demonstrating that b2R1-fructans have the ability to activate
human immune cells. Interestingly, chain length proved to be an
important factor in skewing the cytokine balance. Anti-inflamma-
Figure 6. NF-kB/AP-1 activation of HEK cell lines overexpressing separate TLRs or NODs. Statistical significance levels were determined
with a non-parametric Mann-Whitney U-test for unpaired observations (two-tailed). Mean and SD of NF-kB/AP-1 activation in HEK cell lines stimulated
with b2R1-fructans for 24 h are plotted as percentage of unstimulated controls, which were set to 100%. Dosages are plotted in mg/ml. Endotoxin
free H2O was used as an additional negative control and per cell line the relevant positive controls were applied as mentioned in Table 1.
doi:10.1371/journal.pone.0068367.g006
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tory IL-10 was strongly induced by short chain b2R1-fructans and
a striking correlation was observed between the ratio of IL-10/IL-
12 and the chain lengths of the fibers. The IL-10/IL-12 ratio has
previously been used to evaluate the effects of probiotic bacteria on
immune responses [40,41], and to describe anti-inflammatory
effects of butyrate [42]. It is therefore useful to apply the same
approach to study the effect of prebiotic fibers.
It can be concluded on the basis of our data that the short chain
molecules which are more abundant in ITF I and II, skew the IL-
10/IL-12 ratio in PBMCs more towards IL-10, and thus induce a
more anti-inflammatory balance. When considering that the
proportion of short chain fructans of the GFn type are also
distributed as ITF I.ITF II.ITF III, the results also suggest that
specifically the short chain fructans of the GFn type determine the
outcome of this cytokine ratio. In spite of the fact that longer
chains induced more IL-12 compared to shorter chains, the
induced IL-10/IL-12 ratio is not significantly different from the
ratio measured in the control cells, indicating that they are pro-
inflammatory as compared to the shorter chains but not pro-
inflammatory per se, when compared to controls.
IL-6 production was observed for higher concentrations of ITF
I and II. Although IL-6 production is generally regarded as
proinflammatory, IL-6 can exert several anti-inflammatory effects
such as inhibition of TNF-a function [43], and activation of IL-
1Ra and IL-10 [44]. Only few studies have addressed in vitro
stimulation of immune cells by b2R1-fructans and cytokine
profiles. In a study of Eiwegger et al. [45] three types of prebiotic
oligosaccharides, including a mixture of short chain galactooligo-
saccharides (scGOS) and long chain b2R1-fructans were analysed
for the induction of a selected panel of cytokines in cord blood
mononuclear cells (CBMCs). The mixture containing long chain
b2R1-fructans did not induce IL-10 in these experiments which
corroborates our findings. Long chain b2R1-fructans alone, or
short chain b2R1-fructans were not tested in the Eiwegger study,
which would allow for a more complete comparison with our
results. In supplementation studies in experimental animals, the
observed immune effects with b2R1-fructans such as increased
cytokine productions, increased serum and secretory immuno-
globulins [13,46–49], and increased numbers of IL-10+, TLR2+,
and TLR4+ DCs [50] could be due to direct effects of b2R1-
fructan-mediated TLR activation in the intestine, be it on immune
cells or intestinal epithelial cells [51]. However, the underlying
mechanisms in these in vivo experiments are likely to be more
complex and are probably the result of combined direct and
indirect effects in the intestine.
Also other studies corroborate our findings on chain length
effects and differences in induced immune parameters. In a study
where rats were supplemented with shorter chain b2R1-fructans
(DP2-8), increased ex vivo secretions of IL-10 were observed in
cells from the Peyer’s patches [13,52–54] and mesenteric lymph
nodes [53]. In another study by Ito et al. the effect of different
chain length b2R1-fructans on prebiotic and immunomodulatory
parameters in rats was studied [55]. In this study, b2R1-fructans
supplementation increased the cecal lactobacilli and bifidobacteria
counts and that IgA concentrations were increased in the order
DP4. DP8. DP16. In addition, DP4, DP8, and DP16, but not
DP23, increased IgA-producing plasma cells in the cecal mucosa.
IFN-c and IL-10 production in cecal CD4(+) T cells was enhanced
solely by DP4. These results confirm that in vivo, chain length of
b2R1-fructans is also of importance to the immunological
response and the fact that these parameters were not correlated
to any of the observed bacterial changes suggests that this is a
direct effect on (immune) cells. This size exclusion effect for direct
signalling of b2R1-fructans in vivo was previously suggested by
Seifert and Watzl [8].
As there are many families of PRRs with typical carbohydrate
binding properties and immunomodulatory capacities [56], we
applied a strategy to target TLRs and NODs: as shown in this
study, the activating capacity of b2R1-fructans on THP-1 cells
was MyD88 dependent, and activation of TLR2 expressing HEK
cells was strongly induced, which implies that signalling through
TLRs, and specifically TLR2, is important in the immunomod-
ulatory capacity of b2R1-fructans [11,27,28,57]. Other PRRs, i.e.
C-type Lectin-like receptors or RIG-like receptors do not signal via
MyD88, but utilise other mechanisms and molecules to transduce
their signal [58,59].
When studying b2R1-fructan mediated activation of HEK cells
expressing individual TLRs or NODS, we observed that NF-kB/
AP-1 was strongly induced via activation of TLR2, and to a lesser
extent by TLR4, 5, 7, 8, and NOD2. No activation was observed
for TLR3, 9, or NOD1. TLR3 does not signal to NF-kB/AP-1 via
MyD88 but through its adapter Toll/interleukin-1 receptor
homology-domain-containing adapter-inducing interferon-b
(TRIF) [60]. However, activation by b2R1-fructans was virtually
absent in the THP-1 DefMyD cells, indicating the importance of
MyD88-related TLRs and no involvement of TLR3.
TLR2 has many natural ligands of bacterial, fungal, viral, and
even endogenous nature [61]. One of these is zymosan, a yeast
PAMP consisting of b-glucans [62], which bear similarity to
b2R1-fructans because both are prebiotic polysaccharides with b-
glycosidic bonds. Although b-glucans are different molecules, it is
tempting to speculate that the mechanism of TLR ligation by
b2R1-fructans could be similar to that of b-glucans, but this
requires further biochemical studies.
Another way of inducing different signals might be mechanistic
differences in receptor interactions at the cellular surface. It is
possible that the shorter chains only activate a few receptors at a
time, and the receptors may be located relatively distant from each
other, whereas the longer chain b2R1-fructans might show a
property of clustering the relevant receptors on the membrane,
thereby creating a molecular complex which enhances signal
transduction or alters the downstream outcome. This clustering
mechanism has been described for lipopolysaccharide (LPS),
clustering substantial numbers of TLR4 [63] and may be a
relevant mechanism for other TLRs as well.
To our best knowledge this is the first study addressing the direct
mechanism behind the immunomodulating capacity of specific
b2R1-fructans, with the aim to get more insight into the
protective associations attributed to dietary fibers in epidemiolog-
ical studies [4]. We demonstrated the principle that b2R1-
fructans possess direct signalling capacity on human immune cells,
mainly through TLR2. These results suggest that direct TLR2
signalling events on immune cells could be part of the mechanism
by which IL-10 production is induced in in vivo b2R1-fructan
supplementation studies. Also we show structure-function rela-
tionships in vitro for b2R1-fructans which illustrate that caution
should be taken in ascribing beneficial health effects to families of
molecules with similar structural features, as seemingly minor
differences in chain length could induce opposite effects.
Author Contributions
Conceived and designed the experiments: LV UR DMGP KVMMFHAS
PdV. Performed the experiments: LV UR. Analyzed the data: LV UR
MMF HAS PdV. Contributed reagents/materials/analysis tools: LV UR
DM GP HAS PdV. Wrote the paper: LV MMF PdV.
b2R1-Fructans and Immune Modulation
PLOS ONE | www.plosone.org 10 July 2013 | Volume 8 | Issue 7 | e68367
References
1. acobs DR Jr, Andersen LF, Blomhoff R (2007) Whole-grain consumption is
associated with a reduced risk of noncardiovascular, noncancer death attributed
to inflammatory diseases in the iowa women’s health study. Am J Clin Nutr 85:
1606–1614.
2. Park Y, Subar AF, Hollenbeck A, Schatzkin A (2011) Dietary fiber intake and
mortality in the NIH-AARP diet and health study. Arch Intern Med 171: 1061–
1068.
3. Chuang SC, Norat T, Murphy N, Olsen A, Tjonneland A, et al. (2012) Fiber
intake and total and cause-specific mortality in the european prospective
investigation into cancer and nutrition cohort. Am J Clin Nutr 96: 164–174.
4. Landberg R (2012) Dietary fiber and mortality: Convincing observations that
call for mechanistic investigations. Am J Clin Nutr 96: 3–4.
5. Fardet A (2010) New hypotheses for the health-protective mechanisms of whole-
grain cereals: What is beyond fibre? Nutr Res Rev 23: 65–134.
6. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic
microbiota: Introducing the concept of prebiotics. J Nutr 125: 1401–1412.
7. Vos AP, M’Rabet L, Stahl B, Boehm G, Garssen J (2007) Immune-modulatory
effects and potential working mechanisms of orally applied nondigestible
carbohydrates. Crit Rev Immunol 27: 97–140.
8. Seifert S, Watzl B (2007) Inulin and oligofructose: Review of experimental data
on immune modulation. J Nutr 137: 2563S–2567S.
9. Lomax AR, Calder PC (2009) Probiotics, immune function, infection and
inflammation: A review of the evidence from studies conducted in humans. Curr
Pharm Des 15: 1428–1518.
10. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, et al. (2010)
Prebiotic effects: Metabolic and health benefits. Br J Nutr 104 Suppl 2: S1–63.
11. Vogt LM, Meyer D, Pullens G, Faas MM, Smelt MJ, et al. Immunological
properties of inulin-type fructans. Critical reviews in food science and nutrition
(in press) DOI:10.1080/10408398.2012.656772.
12. Swanson KS, Grieshop CM, Flickinger EA, Healy HP, Dawson KA, et al. (2002)
Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on
immune function and ileal and fecal microbial populations in adult dogs. Arch
Tierernahr 56: 309–318.
13. Hosono A, Ozawa A, Kato R, Ohnishi Y, Nakanishi Y, et al. (2003) Dietary
fructooligosaccharides induce immunoregulation of intestinal IgA secretion by
murine peyer’s patch cells. Biosci Biotechnol Biochem 67: 758–764.
14. Nakamura Y, Nosaka S, Suzuki M, Nagafuchi S, Takahashi T, et al. (2004)
Dietary fructooligosaccharides up-regulate immunoglobulin A response and
polymeric immunoglobulin receptor expression in intestines of infant mice. Clin
Exp Immunol 137: 52–58.
15. Meijer K, de Vos P, Priebe MG (2010) Butyrate and other short-chain fatty acids
as modulators of immunity: What relevance for health? Curr Opin Clin Nutr
Metab Care 13: 715–721.
16. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R (2011) Regulation of
inflammation by short chain fatty acids. Nutrients 3: 858–876.
17. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, et al. (2009) Regulation
of inflammatory responses by gut microbiota and chemoattractant receptor
GPR43. Nature 461: 1282–1286.
18. Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, et al. (2009)
Short-chain fatty acids stimulate the migration of neutrophils to inflammatory
sites. Clin Sci (Lond) 117: 331–338.
19. Park JS, Lee EJ, Lee JC, Kim WK, Kim HS (2007) Anti-inflammatory effects of
short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine
macrophage cells: Involvement of NF-kappaB and ERK signaling pathways.
Int Immunopharmacol 7: 70–77.
20. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, et al. (2011)
Suppressive effect of short-chain fatty acids on production of proinflammatory
mediators by neutrophils. J Nutr Biochem 22: 849–855.
21. McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, et al. (2012)
Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small
intestine. Nature 483: 345–349.
22. Lelouard H, Fallet M, de Bovis B, Meresse S, Gorvel JP (2012) Peyer’s patch
dendritic cells sample antigens by extending dendrites through M cell-specific
transcellular pores. Gastroenterology 142: 592–601.e3.
23. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, et al. (2002)
Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196: 407–
412.
24. Underhill DM, Rossnagle E, Lowell CA, Simmons RM (2005) Dectin-1 activates
syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen
production. Blood 106: 2543–2550.
25. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, et al. (1999) The
toll-like receptor 2 is recruited to macrophage phagosomes and discriminates
between pathogens. Nature 401: 811–815.
26. Janeway CA Jr (1989) Approaching the asymptote? evolution and revolution in
immunology. Cold Spring Harb Symp Quant Biol 54 Pt 1: 1–13.
27. Cambi A, Figdor CG (2003) Dual function of C-type lectin-like receptors in the
immune system. Curr Opin Cell Biol 15: 539–546.
28. Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: How
bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131–144.
29. Kelly G (2008) Inulin-type prebiotics–a review: Part 1. Altern Med Rev 13: 315–
329.
30. Niness KR (1999) Inulin and oligofructose: What are they? J Nutr 129: 1402S-
6S.
31. Chen Z, Cheng Y, Xu Y, Liao J, Zhang X, et al. (2008) Expression profiles and
function of toll-like receptors 2 and 4 in peripheral blood mononuclear cells of
chronic hepatitis B patients. Clin Immunol 128: 400–408.
32. Siednienko J, Miggin SM (2009) Expression analysis of the toll-like receptors in
human peripheral blood mononuclear cells. Methods Mol Biol 517: 3–14.
33. Joosten LA, Heinhuis B, Abdollahi-Roodsaz S, Ferwerda G, Lebourhis L, et al.
(2008) Differential function of the NACHT-LRR (NLR) members Nod1 and
Nod2 in arthritis. Proc Natl Acad Sci U S A 105: 9017–9022.
34. Meijerink M, van Hemert S, Taverne N, Wels M, de Vos P, et al. (2010)
Identification of genetic loci in lactobacillus plantarum that modulate the
immune response of dendritic cells using comparative genome hybridization.
PLoS One 5: e10632.
35. van Hemert S, Meijerink M, Molenaar D, Bron PA, de Vos P, et al. (2010)
Identification of lactobacillus plantarum genes modulating the cytokine response
of human peripheral blood mononuclear cells. BMC Microbiol 10: 293–2180–
10–293.
36. Shalhoub J, Falck-Hansen MA, Davies AH, Monaco C (2011) Innate immunity
and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond) 8: 9.
37. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195–
2224.
38. Abadie V, Discepolo V, Jabri B (2012) Intraepithelial lymphocytes in celiac
disease immunopathology. Semin Immunopathol 34: 551–566.
39. Zheng H, Luo X, Segura M, Sun H, Ye C, et al. (2012) The role of toll-like
receptors in the pathogenesis of streptococcus suis. Vet Microbiol 156: 147–156.
40. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, et al. (2010) Generation of
regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration
suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159–2164.
41. Meijerink M, Wells JM, Taverne N, de Zeeuw Brouwer ML, Hilhorst B, et al.
(2012) Immunomodulatory effects of potential probiotics in a mouse peanut
sensitization model. FEMS Immunol Med Microbiol 65: 488–496.
42. Hamer HM, Jonkers DM, Vanhoutvin SA, Troost FJ, Rijkers G, et al. (2010)
Effect of butyrate enemas on inflammation and antioxidant status in the colonic
mucosa of patients with ulcerative colitis in remission. Clin Nutr 29: 738–744.
43. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK (2003) Exercise
and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.
FASEB J 17: 884–886.
44. Petersen AM, Pedersen BK (2005) The anti-inflammatory effect of exercise.
J Appl Physiol 98: 1154–1162.
45. Eiwegger T, Stahl B, Haidl P, Schmitt J, Boehm G, et al. (2010) Prebiotic
oligosaccharides: In vitro evidence for gastrointestinal epithelial transfer and
immunomodulatory properties. Pediatr Allergy Immunol 21: 1179–1188.
46. Janardhana V, Broadway MM, Bruce MP, Lowenthal JW, Geier MS, et al.
(2009) Prebiotics modulate immune responses in the gut-associated lymphoid
tissue of chickens. J Nutr 139: 1404–1409.
47. Benyacoub J, Rochat F, Saudan KY, Rochat I, Antille N, et al. (2008) Feeding a
diet containing a fructooligosaccharide mix can enhance salmonella vaccine
efficacy in mice. J Nutr 138: 123–129.
48. Saavedra JM, Tschernia A (2002) Human studies with probiotics and prebiotics:
Clinical implications. Br J Nutr 87 Suppl 2: S241–6.
49. van Hoffen E, Ruiter B, Faber J, M’Rabet L, Knol EF, et al. (2009) A specific
mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosac-
charides induces a beneficial immunoglobulin profile in infants at high risk for
allergy. Allergy 64: 484–487.
50. Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, et al. (2006) Clinical,
microbiological, and immunological effects of fructo-oligosaccharide in patients
with crohn’s disease. Gut 55: 348–355.
51. Wells JM, Rossi O, Meijerink M, van Baarlen P (2011) Epithelial crosstalk at the
microbiota-mucosal interface. Proc Natl Acad Sci U S A 108 Suppl 1: 4607–
4614.
52. Roller M, Rechkemmer G, Watzl B (2004) Prebiotic inulin enriched with
oligofructose in combination with the probiotics lactobacillus rhamnosus and
bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 134:
153–156.
53. Roller M, Pietro Femia A, Caderni G, Rechkemmer G, Watzl B (2004)
Intestinal immunity of rats with colon cancer is modulated by oligofructose-
enriched inulin combined with lactobacillus rhamnosus and bifidobacterium
lactis. Br J Nutr 92: 931–938.
54. Manhart N, Spittler A, Bergmeister H, Mittlbock M, Roth E (2003) Influence of
fructooligosaccharides on peyer’s patch lymphocyte numbers in healthy and
endotoxemic mice. Nutrition 19: 657–660.
55. Ito H, Takemura N, Sonoyama K, Kawagishi H, Topping DL, et al. (2011)
Degree of polymerization of inulin-type fructans differentially affects number of
lactic acid bacteria, intestinal immune functions, and immunoglobulin A
secretion in the rat cecum. J Agric Food Chem 59: 5771–5778.
56. Delgado MA, Deretic V (2009) Toll-like receptors in control of immunological
autophagy. Cell Death Differ 16: 976–983.
57. de Kivit S, Kraneveld AD, Garssen J, Willemsen LE (2011) Glycan recognition
at the interface of the intestinal immune system: Target for immune modulation
via dietary components. Eur J Pharmacol.
b2R1-Fructans and Immune Modulation
PLOS ONE | www.plosone.org 11 July 2013 | Volume 8 | Issue 7 | e68367
58. Kerrigan AM, Brown GD (2010) Syk-coupled C-type lectin receptors that
mediate cellular activation via single tyrosine based activation motifs. Immunol
Rev 234: 335–352.
59. Bruns AM, Horvath CM (2012) Activation of RIG-I-like receptor signal
transduction. Crit Rev Biochem Mol Biol 47: 194–206.
60. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate
immunity: Update on toll-like receptors. Nat Immunol 11: 373–384.
61. Oliveira-Nascimento L, Massari P, Wetzler LM (2012) The role of TLR2 in
infection and immunity. Front Immunol 3: 79.
62. Sato M, Sano H, Iwaki D, Kudo K, Konishi M, et al. (2003) Direct binding of
toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation
and TNF-alpha secretion are down-regulated by lung collectin surfactant protein
A. J Immunol 171: 417–425.
63. Visintin A, Latz E, Monks BG, Espevik T, Golenbock DT (2003) Lysines 128
and 132 enable lipopolysaccharide binding to MD-2, leading to toll-like
receptor-4 aggregation and signal transduction. J Biol Chem 278: 48313–48320.
b2R1-Fructans and Immune Modulation
PLOS ONE | www.plosone.org 12 July 2013 | Volume 8 | Issue 7 | e68367
